Inventor · disambiguated record
Yu Feng
Also filed as: FENG YU · Feng yu wen
16 granted patents·11 pending applications·188 citations·filing 1996–2025
91Inventor score
Files withUNIV RUTGERS4CHENGDA PHARMACEUTICALS CO LTD3ABIDE THERAPEUTICS INC2CYTIMM THERAPEUTICS INC2LUNDBECK LA JOLLA RESEARCH CENTER INC2
Top patents by PatentIndex Score
27 records- 0192US5939538AMethods and compositions for inhibiting HIV infection of cells by cleaving HIV co-receptor RNAIMMUSOL INC·Filed 1996·Granted Aug 17, 1999·139 cites·13 claims
- 0287US9605028B2Antibacterial agents: salinamide derivativesUNIV RUTGERS·Filed 2015·Granted Mar 28, 2017·3 cites·14 claims
- 0387US7151087B2CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infectionUS DEPT OF HEALTH AND HUMAN RE·Filed 2003·Granted Dec 19, 2006·17 cites·8 claims
- 0486US11129827B2Dual MAGL and FAAH inhibitorsABIDE THERAPEUTICS INC·Filed 2019·Granted Sep 28, 2021·2 cites·16 claims
- 0582US10966447B2Glucosyringic acid analogs as sweetness profile modifiersPEPSICO INC·Filed 2016·Granted Apr 6, 2021·1 cites·14 claims
- 0681US10350205B2Dual MAGL and FAAH inhibitorsABIDE THERAPEUTICS INC·Filed 2018·Granted Jul 16, 2019·2 cites·17 claims
- 0778US2025262205A1Dual magl and faah inhibitorsLUNDBECK LA JOLLA RESEARCH CENTER INC·Filed 2025·Application pending·0 cites
- 0875US12318383B2Dual MAGL and FAAH inhibitorsLUNDBECK LA JOLLA RESEARCH CENTER INC·Filed 2021·Granted Jun 3, 2025·0 cites·15 claims
- 0975US9221880B2Antibacterial agents: salinamide derivativesUNIV RUTGERS·Filed 2013·Granted Dec 29, 2015·2 cites·15 claims
- 1074US10058604B2Soluble HIV-1 envelope glycoprotein trimersINT AIDS VACCINE INITIATIVE·Filed 2014·Granted Aug 28, 2018·3 cites·17 claims
- 1173US9243039B2Bipartite inhibitors of bacterial RNA polymerase: Sal-target-inhibitor/nucleoside-analog-inhibitor conjugatesUNIV RUTGERS·Filed 2013·Granted Jan 26, 2016·1 cites·30 claims
- 1270US2008241167A1Cc chemokine receptor 5 dna, new animal models and therapeutic agents for hiv infectionGOV T OF THE U S A AS REPRESEN·Filed 2008·Application pending·0 cites
- 1365US6696490B2Slow release insect repellent compounds and process for delivering activeUNILEVER HOME & PERSONAL CARE·Filed 2002·Granted Feb 24, 2004·4 cites·2 claims
- 1462US9809626B2Antibacterial agents: salinamide derivativesUNIV RUTGERS·Filed 2017·Granted Nov 7, 2017·0 cites·3 claims
- 1560US2023032607A1Protein n-terminal de novo sequencing by position-selective dimethylationREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1658US2005064390A1Cells expressing both human CD4 and a human fusion accessory factor associated with HIV infectionFiled 2003·Application pending·0 cites
- 1756US6197578B1Cells expressing both human CD4 and a human fusion accessory factor associated with HIV infectionUS HEALTH·Filed 1997·Granted Mar 6, 2001·14 cites·7 claims
- 1854US2003195348A1CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infectionUS HEALTH·Filed 2003·Application pending·0 cites
- 1953US2024010697A1Modified interleukin 2 (il-2) polypeptides, and methods of making and using the sameCYTIMM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2052US2023242490A1Method for the preparation of sulfinpyrazoneCHENGDA PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 2151US12410131B2Method for preparation of trans-n-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone as intermediate of halofuginoneCHENGDA PHARMACEUTICALS CO LTD·Filed 2022·Granted Sep 9, 2025·0 cites·10 claims
- 2248US2022289806A1Modified Interleukin 2 (IL-2) Polypeptides, Conjugates and Uses ThereofCYTIMM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2347US2025233570A1Resonator chip and manufacturing method thereofTXC CORP·Filed 2024·Application pending·0 cites
- 2444US12234234B2Method for synthesizing 1,7-naphthyridine derivativesCHENGDA PHARMACEUTICALS CO LTD·Filed 2020·Granted Feb 25, 2025·0 cites·13 claims
- 2544US2023390364A1Use of human serum albumin in treatment of diseasesSHENZHEN PROTGEN LTD·Filed 2021·Application pending·0 cites
- 2642US11771660B2Flavonoid polyphenol drug self-emulsifying composition, preparation method therefor, pharmaceutical composition thereof and application thereofBEIJING WEHAND BIO PHARMACEUTICAL CO LTD·Filed 2020·Granted Oct 3, 2023·0 cites·16 claims
- 2742US2003039955A1Compositions and methods for production of RNA viruses and RNA virus-based vector particlesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yu Feng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →